与结核分枝杆菌链霉素依赖性相关的16S核糖体RNA新突变
Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis.
作者信息
Honoré N, Marchal G, Cole S T
机构信息
Unité de Génétique Moléculaire Bactérienne, Institut Pasteur, Paris, France.
出版信息
Antimicrob Agents Chemother. 1995 Mar;39(3):769-70. doi: 10.1128/AAC.39.3.769.
Abstract
Molecular characterization of a streptomycin-dependent mutant of Mycobacterium tuberculosis revealed the presence of a novel mutation in the rrs gene encoding 16S rRNA. Insertion of an additional cytosine in the 530 loop of 16S rRNA, a region known to be involved in streptomycin susceptibility and resistance, was associated with streptomycin dependence.
摘要
结核分枝杆菌链霉素依赖突变体的分子特征揭示，在编码16S rRNA的rrs基因中存在一个新突变。在16S rRNA的530环中额外插入一个胞嘧啶，该区域已知与链霉素敏感性和耐药性有关，这与链霉素依赖相关。
相似文献
1
Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis.与结核分枝杆菌链霉素依赖性相关的16S核糖体RNA新突变
Antimicrob Agents Chemother. 1995 Mar;39(3):769-70. doi: 10.1128/AAC.39.3.769.
2
A ribosomal gene mutation in streptomycin-resistant Mycobacterium tuberculosis isolates.耐链霉素结核分枝杆菌分离株中的核糖体基因突变。
J Infect Dis. 1993 Jun;167(6):1505-6. doi: 10.1093/infdis/167.6.1505.
3
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.结核分枝杆菌中链霉素耐药性的分子基础：核糖体蛋白S12基因的改变及功能性16S核糖体RNA假结内的点突变
Mol Microbiol. 1993 Sep;9(6):1239-46. doi: 10.1111/j.1365-2958.1993.tb01253.x.
4
Streptomycin resistance in mycobacteria.分枝杆菌中的链霉素耐药性。
Antimicrob Agents Chemother. 1994 Feb;38(2):238-42. doi: 10.1128/AAC.38.2.238.
5
Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance.耐链霉素结核分枝杆菌的基因改变：赋予耐药性的突变图谱
Antimicrob Agents Chemother. 1994 Feb;38(2):228-33. doi: 10.1128/AAC.38.2.228.
6
Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis.结核分枝杆菌中与链霉素耐药相关的基因组突变预测值的地理变异。
Mol Cell Probes. 1997 Apr;11(2):123-6. doi: 10.1006/mcpr.1996.0086.
7
Investigation of the in vitro activity of streptomycin against Mycobacterium tuberculosis.链霉素对结核分枝杆菌的体外活性研究。
Microb Drug Resist. 2002 Summer;8(2):147-9. doi: 10.1089/107662902760190707.
8
Molecular characterisation of streptomycin-resistant Mycobacterium tuberculosis strains isolated in Poland.波兰分离出的耐链霉素结核分枝杆菌菌株的分子特征分析
Int J Tuberc Lung Dis. 2004 Aug;8(8):1032-5.
9
Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria.16S核糖体RNA中保守的7-甲基鸟苷修饰缺失赋予细菌低水平链霉素抗性。
Mol Microbiol. 2007 Feb;63(4):1096-106. doi: 10.1111/j.1365-2958.2006.05585.x.
10
Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City.纽约市患者结核分枝杆菌分离株中链霉素耐药机制的特征分析
Antimicrob Agents Chemother. 1996 May;40(5):1186-8. doi: 10.1128/AAC.40.5.1186.
引用本文的文献
1
Differential Selection for Translation Efficiency Shapes Translation Machineries in Bacterial Species.细菌物种中翻译效率的差异选择塑造了翻译机制。
Microorganisms. 2024 Apr 10;12(4):768. doi: 10.3390/microorganisms12040768.
2
Dormancy: How to Fight a Hidden Danger.休眠：如何应对隐藏的危险。
Microorganisms. 2022 Nov 25;10(12):2334. doi: 10.3390/microorganisms10122334.
3
Antibiotic Combination Therapy: A Strategy to Overcome Bacterial Resistance to Aminoglycoside Antibiotics.抗生素联合疗法：一种克服细菌对氨基糖苷类抗生素耐药性的策略。
Front Pharmacol. 2022 Feb 23;13:839808. doi: 10.3389/fphar.2022.839808. eCollection 2022.
4
The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem.链霉素对结核病耐药问题的被忽视的贡献。
Genes (Basel). 2021 Dec 17;12(12):2003. doi: 10.3390/genes12122003.
5
Aminoglycoside Revival: Review of a Historically Important Class of Antimicrobials Undergoing Rejuvenation.氨基糖苷类药物的复兴：对一类正在经历复兴的具有历史重要性的抗菌药物的综述
EcoSal Plus. 2018 Nov;8(1). doi: 10.1128/ecosalplus.ESP-0002-2018.
6
Activity of Moxifloxacin against in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model.莫西沙星对中空纤维感染模型酸相和非复制持久表型相 的活性。
Antimicrob Agents Chemother. 2018 Nov 26;62(12). doi: 10.1128/AAC.01470-18. Print 2018 Dec.
7
The Phagocyte Oxidase Controls Tolerance to Infection.吞噬细胞氧化酶控制感染的耐受性。
J Immunol. 2018 Sep 15;201(6):1705-1716. doi: 10.4049/jimmunol.1800202. Epub 2018 Jul 30.
8
Insights into microbial cryptic gene activation and strain improvement: principle, application and technical aspects.微生物隐秘基因激活与菌株改良的见解：原理、应用及技术层面
J Antibiot (Tokyo). 2017 Jan;70(1):25-40. doi: 10.1038/ja.2016.82. Epub 2016 Jul 6.
9
Genomic and transcriptomic analysis of the streptomycin-dependent Mycobacterium tuberculosis strain 18b.链霉素依赖型结核分枝杆菌菌株18b的基因组和转录组分析。
BMC Genomics. 2016 Mar 5;17:190. doi: 10.1186/s12864-016-2528-2.
10
The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?耐药性对结核分枝杆菌生理学的影响：从利福平我们能学到什么？
Emerg Microbes Infect. 2014 Mar;3(3):e17. doi: 10.1038/emi.2014.17. Epub 2014 Mar 12.
本文引用的文献
1
Streptomycin resistance in mycobacteria.分枝杆菌中的链霉素耐药性。
Antimicrob Agents Chemother. 1994 Feb;38(2):238-42. doi: 10.1128/AAC.38.2.238.
2
Genetic alterations in streptomycin-resistant Mycobacterium tuberculosis: mapping of mutations conferring resistance.耐链霉素结核分枝杆菌的基因改变：赋予耐药性的突变图谱
Antimicrob Agents Chemother. 1994 Feb;38(2):228-33. doi: 10.1128/AAC.38.2.228.
3
The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis.结核分枝杆菌单耐药和多耐药菌株中的rpsL基因与链霉素耐药性
Mol Microbiol. 1993 Nov;10(3):521-7. doi: 10.1111/j.1365-2958.1993.tb00924.x.
4
Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot.结核分枝杆菌中链霉素耐药性的分子基础：核糖体蛋白S12基因的改变及功能性16S核糖体RNA假结内的点突变
Mol Microbiol. 1993 Sep;9(6):1239-46. doi: 10.1111/j.1365-2958.1993.tb01253.x.
5
Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study.多重耐药对结核病短程化疗未来的影响：一项分子研究。
Lancet. 1994 Jul 30;344(8918):293-8. doi: 10.1016/s0140-6736(94)91338-2.
6
Resistance to drugs targeting protein synthesis in mycobacteria.分枝杆菌对靶向蛋白质合成的药物的耐药性。
Trends Microbiol. 1994 Oct;2(10):416-21. doi: 10.1016/0966-842x(94)90622-x.
7
Amino acid replacements in proteins S5 and S12 of two Escherichia coli revertants from streptomycin dependence to independence.两个从链霉素依赖型回复为非依赖型的大肠杆菌回复突变体中蛋白质S5和S12的氨基酸替换。
Mol Gen Genet. 1973 Dec 14;127(1):19-32. doi: 10.1007/BF00267779.
8
Ribosomal proteins. 33. Location of amino-acid replacements in protein S12 isolated from Escherichia coli mutants resistant to streptomycin.核糖体蛋白。33. 从抗链霉素的大肠杆菌突变体中分离出的蛋白质S12中氨基酸替换的位置。
J Mol Biol. 1972 Jul 28;68(3):547-50. doi: 10.1016/0022-2836(72)90108-8.
9
Mycobacteria possess a surprisingly small number of ribosomal RNA genes in relation to the size of their genome.与基因组大小相比，分枝杆菌拥有数量惊人少的核糖体RNA基因。
Biochem Biophys Res Commun. 1986 May 14;136(3):1136-41. doi: 10.1016/0006-291x(86)90452-3.
10
Interaction of antibiotics with functional sites in 16S ribosomal RNA.抗生素与16S核糖体RNA功能位点的相互作用。
Nature. 1987;327(6121):389-94. doi: 10.1038/327389a0.
Zotero 插件